商品名: Dehydronandrolone Acetate
同義語: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
MP: 95-98℃
保存温度: Controlled Substance, -20°C Freezer
外観: 白い粉
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is an effective compound that produces quality, long-lasting muscle gains,with the biggest side effect being water retention.
| Items of analysis |
仕様 |
結果 |
| Description |
White to light yellow crystalline powder |
白色結晶性粉末 |
| 融点 |
≥100℃ |
107℃ |
| Specific optical rotation |
-20°～-26° |
-22.5° |
| Loss on Drying |
≤0.5% |
0.15% |
| 識別 |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
資格のある |
| Maximum single impurity |
≤1.0% |
0.3% |
| 総不純物 |
≤5.0% |
0.8% |
| アッセイ |
≥95.0% |
99.45% |
| 結論 |
資格のある |
